PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'China Academy of Chinese Medical Sciences Institute of Basic Research in Clinical Medicine, Beijing, China.\', \'China Academy of Chinese Medical Sciences Xiyuan Hospital, Beijing, China.\', \'Wuhan Jinyintan Hospital, Wuhan, Hubei, China.\', \'China Academy of Chinese Medical Sciences, Beijing, China.\', \'China Academy of Chinese Medical Sciences Institute of Chinese Materia Medica, Beijing, China.\', \'China Academy of Chinese Medical Sciences Guanganmen Hospital, Beijing, China.\', \'China Academy of Chinese Medical Sciences Chinese Materia Medica Resource Center, Beijing, China.\', \'China Academy of Chinese Medical Sciences, Beijing, China; China Center for Evidence-based Medicine of Traditional Chinese Medicine, China Academy of Chinese Medical Sciences, Beijing, China. Electronic address: huangluqi01@126.com.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S0944-7113(21)00214-210.1016/j.phymed.2021.153671
?:hasPublicationType
?:journal
  • Phytomedicine : international journal of phytotherapy and phytopharmacology
is ?:pmid of
?:pmid
?:pmid
  • 34425471
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Combination of Hua Shi Bai Du granule (Q-14) and standard care in the treatment of patients with coronavirus disease 2019 (COVID-19): A single-center, open-label, randomized controlled trial.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all